Phase II Study to Evaluate Safety and Immunogenicity of a Chikungunya Vaccine
Clinical trial NCT02861586 · COMPLETED
Trial details
- NCT number
- NCT02861586
- Sponsor
- Themis Bioscience GmbH
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-08-17
- Primary completion
- 2017-09-01
- Enrollment
- 263
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.